Dr. Carol Ann French, D.M.D. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: #1 Thames Alley, Irmo, SC 29063 Phone: 803-781-2511 Fax: 803-781-8401 |
Dr. George Franklin Causey Jr., DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7319 College Street, Irmo, SC 29063 Phone: 803-781-1990 Fax: 803-781-1947 |
Joshua Fulton, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7897 Broad River Rd, Irmo, SC 29063 Phone: 803-781-2439 |
Dr. Ralph Edward Taylor Jr., DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1032c Kinley Rd, Irmo, SC 29063 Phone: 803-781-3232 |
Dr. Morgan Leigh Herrington, DMD Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1544 Old Tamah Rd, Irmo, SC 29063 Phone: 803-732-7223 |
Dr. Gregory Joseph Wych, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7505 Saint Andrews Rd, Irmo, SC 29063 Phone: 803-781-1600 Fax: 803-781-8634 |
News Archive
In this GlobalPost opinion piece, Zulfiqar Bhutta, Husein Laljee Dewraj professor and head of the Division of Maternal and Child Health at the Aga Khan University Medical Center in Karachi, Pakistan, and Ciro de Quadros, executive vice president of the Sabin Vaccine Institute and former director of the Division of Vaccines and Immunization at PAHO, examine the need for a dengue fever vaccine as Pakistan struggles to curb an outbreak of the disease that to date has killed 60 people and has infected more than 8,000.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced results for the first quarter ended March 31, 2012. Revenue for the first quarter was $32.5 million, an increase of $6.0 million, or 23%, as compared to the first quarter of 2011.
PBS NewsHour's blog "The Rundown" examines "a recent slate of independent studies" that assert "Twitter can accurately track the spread of a virus or disease - and do it much faster than traditional surveillance methods."
Takeda Canada, Inc. is pleased to announce that ULORICĀ® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
› Verified 9 days ago